Sweet Chemistry, Inc.

Based in the US, Sweet Chemistry, Inc. offers innovative skincare solutions featuring scientifically formulated products that utilize advanced polypeptide technology to improve skin health and appearance. Sweet Chemistry, Inc. was founded in 2023 and is headquartered in New York, US.

The company focuses on developing peptide-based skincare products. In October 2025, the firm raised USD 1 million in funding led by Sandbridge Capital to enhance its R&D efforts. The founder's history is not detailed in the provided information. Sweet Chemistry, Inc.

specializes in innovative skincare solutions through its flagship line that includes products featuring 3% Matrikynes® polypeptides. These products address skin concerns like barrier repair and hydration while reducing fine lines. They employ patent-pending Matrikynes® derived from natural extracellular matrix to improve skin density and texture, catering to various skin types with a range of offerings. Revenue for Sweet Chemistry, Inc.

is generated through direct-to-consumer sales and retail partnerships, with a focus on affordable luxury. Products such as the Barrier Repairing Hydra-Serum and Elasticity Reinforcing Hydra-Cream are available on the company’s e-commerce platform, supporting single purchases and subscription models. The pricing reflects the premium nature of its proprietary Matrikynes® technology. In October 2025, Sweet Chemistry, Inc.

raised USD 1 million in venture funding led by Sandbridge Capital to advance the research and development of peptide-based skincare products. The company plans to launch new products that will enhance its existing line. Going forward, Sweet Chemistry aims to expand into new markets, targeting both North America and selected international regions by the end of 2026.